UNSPSC 51420000: Corticosteroids

This classification denotes manufactured adrenal cortex hormones (chemical substances having a specific regulatory effect on the activity of a certain organ or organs) or steroids that are similar to cortisol, the main glucocorticoid secreted by the adrenal cortex, or outer layer of the adrenal gland.

UNSPSC 51420000 Corticosteroids is a Family code that covers pharmaceutical and medical products; however, the recent state and local contracting activity under this code does not align with corticosteroid procurement. Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023, seeks to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding. This opportunity reflects actual buying patterns under the code at the issuing-body level — a single county government health agency — though the scope (opioid-overdose reversal medication and drug destruction equipment) diverges significantly from the code's nominal pharmaceutical classification. Vendors must submit electronic bids through Seminole County's e-Procurement Portal, include all shipping and delivery costs, hold E-Verify compliance and drug-free workplace certification, and maintain workers' compensation, commercial general liability, and professional liability insurance. The contract carries a two-year initial term with a one-year renewal option and includes a three-month probationary period permitting termination at will.

Seminole County represents the sole recent opportunity identified under this code, with quarterly deliveries to the county's community health building in Sanford, Florida. The procurement may draw FEMA funding and incorporates federal compliance obligations including the Clean Air Act and Federal Water Pollution Control Act. No explicit set-aside designations for disadvantaged enterprises appear in the solicitation documents. The narrow activity and scope mismatch suggest that this UNSPSC code sees limited recent state and local procurement volume, or that opportunities posted under it do not consistently reflect the pharmaceutical products the code nominally covers.